When Moderna submitted its FDA request for the emergency use authorization of a second booster shot of its COVID-19 vaccine, the drugmaker included all adults. CEO Stephane Bancel told CNBC this choice was meant to give the agency flexibility in determining who would be eligible to receive the second shot.
